ArticleCancer medicine2023

Apalutamide for prostate cancer: Multicentre and multidisciplinary real-world study of 227 patients.

Julián Córdoba Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.